Precision Biosciences (DTIL) Profit After Tax (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -195.81% |
| Dec 31, 2025 | 188.41% |
| Sep 30, 2025 | 7.43% |
| Jun 30, 2025 | -14.37% |
| Mar 31, 2025 | -15.89% |
| Dec 31, 2024 | -8.04% |
| Sep 30, 2024 | -150.15% |
| Jun 30, 2024 | 281.33% |
| Mar 31, 2024 | 152.72% |
| Dec 31, 2023 | -34.51% |
| Sep 30, 2023 | -1.84% |
| Jun 30, 2023 | 52.55% |
| Mar 31, 2023 | 56.91% |
| Dec 31, 2022 | -270.63% |
| Sep 30, 2022 | 49.44% |
| Jun 30, 2022 | -10.18% |
| Mar 31, 2022 | -26.37% |
| Dec 31, 2021 | -97.62% |
| Sep 30, 2021 | -152.08% |
| Jun 30, 2021 | 215.88% |
| Mar 31, 2021 | 20.31% |
| Dec 31, 2020 | 9.85% |
| Sep 30, 2020 | 20.44% |
| Jun 30, 2020 | -21.85% |
| Mar 31, 2020 | -28.30% |
| Dec 31, 2019 | -0.84% |
| Sep 30, 2019 | -6.72% |
| Jun 30, 2019 | 38.85% |
| Mar 31, 2019 | -105.81% |
| Dec 31, 2018 | -58.29% |
| Sep 30, 2018 | 17.50% |
| Jun 30, 2018 | -31.23% |